Treatment strategies in low-volume metastatic castration-resistant prostate cancer Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Brachytherapy
  • Prostate-Specific Antigen
  • Prostatic Neoplasms

abstract

  • Prospective studies are needed to establish optimal therapeutic approaches in carefully selected low-volume mCRPC patients. Advances in functional imaging and molecular profiling should provide opportunities to optimize patient selection for effective treatment strategies.

publication date

  • November 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/MOU.0000000000000436

PubMed ID

  • 28786849

Additional Document Info

start page

  • 596

end page

  • 603

volume

  • 27

number

  • 6